Both in Pharmaceuticals
Foghorn Therapeutics vs Spruce Biosciences
Over the past year FHTX returned −49.4% and SPRB returned −59.1%; their daily moves had a correlation of 0.20.
FHTX −49.4% SPRB −59.1%Growth of $1, one year, split-adjusted
| Metric | FHTX | SPRB |
|---|---|---|
| Price | $2.11 | $43.38 |
| Market cap | $125.0M | $124.7M |
| Today | −1.17% | −2.63% |
| 1 month | +5.3% | −4.5% |
| 6 months | −54.6% | −26.9% |
| Year to date | −61.0% | −50.2% |
| 1 year | −52.3% | −60.6% |
| Revenue growth (YoY) | +112.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −44.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.4× | — |
| Net cash | $167.6M | $89.2M |
| Dividend yield | — | — |
| Volatility (60d) | 99.0% | 64.2% |
| Short % of float | 7.3% | 22.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).